As a clinical trial professional, we understand your positive impact on trial development, planning, execution, quality, and data generation. This year's
CROWN Congress will review the clinical trial landscape, providing in-depth sessions on the approaches, innovations, and collaborations that are accelerating clinical trials.
Now in its 8th consecutive year, the
CROWN Congress will highlight additional areas such as clinical risk management, outsourcing strategies, operational metrics, risk-based monitoring, patient engagement, and more!
Start your year off right by receiving the latest strategies, trends, tools and technologies needed to advance clinical trials, and make the connections needed to position your company for success in 2019.
Who Should Attend
This conference is designed for professionals from pharmaceutical, biotechnology and medical device companies; CROs; and other service providers involved with developing, executing, managing and optimizing clinical trials. Attendees' job responsibilities include:
- Clinical Operations
- Clinical Research
- Clinical Development
- Clinical Outsourcing/Vendor Selection and Management
- Clinical Management/Oversight
- Clinical Quality
- Clinical Compliance
- Patient Recruitment/ Engagement/Enrollment
- Study Management/Clinical Project Management
- Good Clinical Practice/GCP
- Clinical Monitoring
- Clinical Data Management
- Clinical Trial Design
- Clinical Site Selection/Contracting/Management
- Clinical Sourcing/Strategic Sourcing/Procurement
Speakers
- Gail Adinamis, CEO, GLOBALCARE CLINICAL TRIALS, LTD
- Bhanu Bahl, Director, Clinical and Translational Science Center, HARVARD MEDICAL SCHOOL
- Stephen Brannan, M.D., Chief Medical Officer, KARUNA PHARMACEUTICALS
- Liza Brienza, Director, GCP Inspection Management, MERCK
- Paul Chew, M.D., Chief Medical Officer, PHESI
- Steven E. Cohen, M.D, Executive Director, Search & Evaluation, Global Business Development, & Translational Medicine, DAIICHI SANKYO, INC.
- Franco Davi, Senior Clinical Program Leader, gRED Clinical Operations, GENENTECH, INC
- Dany DeGrave, Senior Director Innovation Programs & External Networks, SANOFI
- Dominique Duchesne, Director, Clinical Operations Lead, BRISTOL-MYERS SQUIBB
- Betsy Fallen, Special Topics Consultant, SAFE BIOPHARMA ASSOCIATION
- Federico Feldstein, Vice President, Head of Quality and Compliance, JOHNSON & JOHNSON
- Janet Freeman, Stage IV Lung Cancer Survivor, PATIENT ADVOCATE
- Madeline Geday, Associate Director, Patient and Stakeholder Engagement Lead, Global Operations, MERCK
- Leesa Gentry, Director, Clinical Management, OTSUKA PHARMACEUTICAL
- Janis Hall, Senior Consultant, THE AVOCA GROUP
- Ann Hegarty, Exec. Director GSMO - Head of CRO Oversight and Phase I, ALLERGAN
- Karrie A. Hilsinger, Director, Global Development Operations, MALLINCKRODT PHARMACEUTICALS
- Reginald Hooks, Associate Director, Clinical Operations, ACADIA PHARMACEUTICALS
- Alex (Wen-Yaw) Hsieh, Director - Clinical Development Quality, PFIZER
- Gloria I-Hsuan Jen, Director of Clinical Operations, SRI INTERNATIONAL
- Dina Katabi, Ph.D., MacArthur Fellow, Andrew and Erna Viterbi Professor, Director of MIT Center for Wireless Networks and Mobile Computing, MIT
- Mitchell Katz, Vice President, Development Operations, FERRING PHARMACEUTICALS
- Kelly Koziol, Client Services Lead, 4G CLINICAL
- Randy Krauss, Head Clinical Performance and Analytics, MERCK
- Jim Kremidas, Executive Director, ASSOCIATION OF CLINICAL RESEARCH PROFESSIONALS
- Aubri Lang, Clinical Trial Manager, TESARO, INC
- Manny Lazaro, Vice President, Head of Clinical Operations, JOUNCE THERAPEUTICS
- Atul Mahableshwarkar, M.D., DFAPA, Vice President, Clinical Development, BLACKTHORN THERAPEUTICS
- Amanda J. Moore, MSHS, Associate Director Clinical Operations and Development, SAGE THERAPEUTICS
- Harald Murck, Adjunct Professor, UNIVERSITY OF MARBURG
- Sabrina Paganoni, Assistant Professor, Massachusetts General Hospital, SPAULDING REHAB HOSPITAL
- Costa Panagos, president, clinical operations, IQVIA
- Rajneesh Patil, BDS., MBA., FPH., Senior Director, Head - Process, Technology and Analytics, Clinical Operations, IQVIA
- Kristen Perkins, Clinical Trial Manager, TESARO, INC.
- Josh Rose, VP, Global Head of Strategy, Research and Development Solutions, IQVIA
- Michael Rosenblatt, Global Head, Clinical Operations Systems and Processes, GENENTECH, INC
- Joshua Rubin, J.D., MBA, MPP, MPH, Program Officer for Learning Health System Initiatives, UNIVERSITY OF MICHIGAN MEDICAL SCHOOL DEPARTMENT OF LEARNING HEALTH SCIENCES
- Dennis Salotti, M.S., MBA, CCRA, Chief Operating Officer, THE AVOCA GROUP
- Michelle Shogren, Head of Innovation, Portfolio and Operations, BAYER
- Supriya Shoroff, Associate Director, TMF, AMAG PHARMACEUTICALS
- Stella Stergiopoulos, Senior Project Manager, TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT
- Jay Turpen, Senior Consultant, THE AVOCA GROUP
- David Vulcano, Vice President, Research Compliance and Integrity, HCA HEALTHCARE
- Alana Wriggins, Head, Global Clinical Site Management, Acquisition Assessments and Clinical records Management, ALLERGAN
- Jean-David Zeitoun, Chief Medical Officer, INATO
Please fill in your name and email to receive the Conference Agenda of this event.
Seminars - January 22, 2019
Conference Day One - January 23, 2019
Conference Day Two - January 24, 2019
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Venue
Hilton Orlando Lake Buena Vista1751 Hotel Plaza Boulevard
Lake Buena Vista, Florida 32830
Experience a relaxing retreat within walking distance to Disney Springs. Our resort features shuttle service to Disney Theme Parks and Disney Springs, delectable dining options, two heated outdoor pools, an arcade and Disney Character Breakfast on Sundays at Covington Mill.
To make reservations, guests can call 1-800-782-4414 and request the negotiated rate for ExL's January Meetings. To make reservations online
Click HereThe group rate is available until January 3, 2019. Please book your room early, as rooms available at this rate are limited.
